Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
0.00%
)
Bitcoin
68,751.90
(
-0.20%
)
News Focus
News Focus
Post# of 257268
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 112128

Wednesday, 08/14/2013 4:40:08 PM

Wednesday, August 14, 2013 4:40:08 PM

Post# of 257268
FRX—NDA submission for aclidinium/formoterol LAMA/LABA combination is delayed due to CMC issues:

http://finance.yahoo.com/news/forest-laboratories-almirall-decide-delay-200200379.html

Aclidinium bromide as a monotherapy is already FDA approved for COPD under the brand name, Tudorza Pressair (#msg-77786338).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now